Fused imidazole derivatives as TRPV3 antagonist
Details for Australian Patent Application No. 2009332651 (hide)
International Classifications
Event Publications
24 November 2011 Section 223 Application Allowed
Glenmark Pharmaceuticals, S.a. The time in which to enter the National Phase has been extended to 26 Oct 2011. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Melbourne VIC 3000 Extensions of Time, Section 223 2010
1 December 2011 PCT application entered the National Phase
PCT publication WO2010/073128 Priority application(s): WO2010/073128
3 May 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 15 Mar 2012
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser